Showing results (421-430 of 454) with videos related to

Sort By:
Pageof 46
The Lancet. Oncology|June 9, 2017
European Association for Neuro-Oncology (EANO) guidelines for palliative care in adults with gliomaAndrea Pace, Linda Dirven, Johan A F Koekkoek, et al.
Breast (Edinburgh, Scotland)|August 10, 2018
T-DM1 and brain metastases: Clinical outcome in HER2-positive metastatic breast cancerAlessandra Fabi, Daniele Alesini, Enrichetta Valle, et al.
Frontiers in Oncology|April 24, 2025
Adjuvant systemic therapy in early breast cancer and results of a prospective observational multicenter BRIDE study: patients outcome and adherence to guidelines in cancer clinical practiceStefania Gori, Alessandra Fabi, Catia Angiolini, et al.
NPJ Breast Cancer|February 5, 2025
Accessible model predicts response in hormone receptor positive HER2 negative breast cancer receiving neoadjuvant chemotherapyLuca Mastrantoni, Giovanna Garufi, Giulia Giordano, et al.
Cancer Treatment Reviews|August 29, 2024
Parp-inhibitors in the therapeutic landscape of breast cancer patients with BRCA1 and BRCA2 pathogenic germline variants: An Italian consensus paper and critical reviewAlberto Zambelli, Laura Cortesi, Mariangela Gaudio, et al.
Biosensors & Bioelectronics|February 7, 2023
AstroBio-CubeSat: A lab-in-space for chemiluminescence-based astrobiology experimentsDonato Calabria, Ilaria Trozzi, Elisa Lazzarini, et al.
Journal of Cellular Physiology|November 19, 2016
A Real-World Multicentre Retrospective Study of Paclitaxel-Bevacizumab and Maintenance Therapy as First-Line for HER2-Negative Metastatic Breast CancerTeresa Gamucci, Lucia Mentuccia, Clara Natoli, et al.
NPJ Breast Cancer|May 6, 2021
PONDx: real-life utilization and decision impact of the 21-gene assay on clinical practice in ItalyFrancesco Cognetti, Riccardo Masetti, Alessandra Fabi, et al.
Eclinicalmedicine|May 31, 2023
Prognostic and clinical impact of the endocrine resistance/sensitivity classification according to international consensus guidelines for advanced breast cancer: an individual patient-level analysis from the Mammella InterGruppo (MIG) and Gruppo Italiano Mammella (GIM) studiesMatteo Lambertini, Eva Blondeaux, Giancarlo Bisagni, et al.
Neurology|June 3, 2021
Prospective Evaluation of Health Care Provider and Patient Assessments in Chemotherapy-Induced Peripheral NeurotoxicityPaola Alberti, Davide P Bernasconi, David R Cornblath, et al.
Pageof 46